Study taxonomy. by Katrine Carlsen (5477300)

Subjects:

Microbiome profile of the most abundant phyla in one patient (Patient 1), across 12 infliximab treatments (-1 is the week before treatment, -2 the two weeks before treatment, etc). by Katrine Carlsen (5477300)

Subjects:

S5 Fig - by Katrine Carlsen (5477300)

Subjects:

Summary statistics for analysis of single family clades. by Katrine Carlsen (5477300)

Subjects:

STORMS microbiome reporting checklist. by Katrine Carlsen (5477300)

Subjects:

Clinical symptoms scoring system. by Llum Páez (22553360)

“…Vaccination against canine leishmaniasis intends to decrease the parasite burden and the risk of clinical disease. …”

eQTL analysis of significant SNPs. by Dai Nogimura (21445649)

Subjects:

Significant associations in the candidate gene approach. by Dai Nogimura (21445649)

Subjects:

The flow-diagram for the randomised clinical study. by Iva Milinkovic (22331710)

Subjects:

The Human Disharmony Loop (central). by James M. Friedman (22522150)

Subjects:

Infection of humanized mice resulted in decrease in pathogenicity in HTLV-1-CTCF infected mice. by Ancy Joseph (5634794)

Summary of post-treatment CAPS score changes from clinical trials with psychotherapies. by Filip Stanicic (17808254)

Summary of clinical studies of FDA-approved medications for PTSD: Disease course outcomes. by Filip Stanicic (17808254)

Summary of post-treatment disease course measures from clinical trials with psychotherapies. by Filip Stanicic (17808254)

The Human Disharmony Loop Clinical Presentation. by James M. Friedman (22522150)

Subjects:

Diagram of the mediating model of the relationship between increased inhibition in the increase of mindfulness level and the decrease of mobile phone addiction index. by Jizhao Li (5856650)

GLM models for predictors of monthly HIV costs. by Drew B. Cameron (10687420)

Subjects:

Median cost (USD) per visit breakdown. by Drew B. Cameron (10687420)

Subjects:

Clinical characteristics. by Huimin Xian (20390006)

“…</p><p>Conclusions</p><p>In patients with MVD-STEMI, the incidence of MACEs was lower in FCR than in FIR, and the decrease was particularly significant in the DM cohort. …”

Table 1_Dexmedetomidine decreases cerebral hyperperfusion syndrome incidence following mechanical thrombectomy in acute ischemic stroke: a double-blind, randomized controlled trial... by Ziwen Gao (11627802)